XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people ... Jan 15
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences... Jan 15
-Advertisements-